OncoTherapy Science (TSE:4564) Change In Inventory: 円0.0 Mil (TTM As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4564 OncoTherapy Science Inc TSE:4564
51 GF Score
Price 円20.00
GF Value 円18.22
Valuation Fairly Valued
! 1 Warning Sign
View Full Analysis

What is OncoTherapy Science Change In Inventory?

OncoTherapy Science TSE:4564 -4.76% 51 Change In Inventory is 円0.0 Mil as of Mar. 2026. GuruFocus rates TSE:4564 with a GF Score™ of 51/100 and a GF Value™ of 円18.22 (Fairly Valued). The stock has 1 warning sign investors should review.

OncoTherapy Science's change in inventory for the quarter that ended in Mar. 2026 was 円0.0 Mil. It means OncoTherapy Science's inventory stayed the same from Dec. 2025 to Mar. 2026 .

OncoTherapy Science's change in inventory for the fiscal year that ended in Mar. 2026 was 円16.4 Mil. It means OncoTherapy Science's inventory declined by 円16.4 Mil from Mar. 2025 to Mar. 2026 .

OncoTherapy Science's Total Inventories for the quarter that ended in Mar. 2026 was 円62.4 Mil.

Days Inventory indicates the number of days of goods in sales that a company has in the inventory. OncoTherapy Science's Days Inventory for the quarter that ended in Mar. 2026 was 36.83.

Inventory Turnover measures how fast the company turns over its inventory within a year. OncoTherapy Science's Inventory Turnover for the quarter that ended in Mar. 2026 was 2.48.

Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue. OncoTherapy Science's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.41.

OncoTherapy Science  (TSE:4564) Change In Inventory Explanation

1. Days Inventory indicates the number of days of goods in sales that a company has in the inventory.

OncoTherapy Science's Days Inventory for the quarter that ended in is calculated as:

Days Inventory=Average Total Inventories/Cost of Goods Sold*Days in Period
=86.575/214.507*365 / 4
=36.83

2. Inventory Turnover measures how fast the company turns over its inventory within a year.

OncoTherapy Science's Inventory Turnover for the quarter that ended in Mar. 2026 is calculated as

Inventory Turnover=Cost of Goods Sold / Average Total Inventories
=214.507 / 86.575
=2.48

3. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.

OncoTherapy Science's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as

Inventory-to-Revenue=Average Total Inventories / Revenue
=86.575 / 211.034
=0.41

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Change In Inventory Related Terms

OncoTherapy Science Change In Inventory Historical Data

* Premium members only.

The historical data trend for OncoTherapy Science's Change In Inventory can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

OncoTherapy Science Change In Inventory Chart

OncoTherapy Science Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Change In Inventory
Get a 7-Day Free Trial Premium Member Only Premium Member Only -189.97 131.42 25.62 -4.87 16.43

OncoTherapy Science Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Change In Inventory Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
TSE:4564
51GF Score
OncoTherapy Science Inc TSE:4564
Change In Inventory is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

OncoTherapy Science Change In Inventory Calculation

Change In Inventory is the difference between last period's ending inventory and the current period's ending inventory.

Change In Inventory for the trailing twelve months (TTM) ended in Mar. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Change In Inventory →
What does a Change In Inventory of 円0.0 Mil mean?
OncoTherapy Science (TSE:4564) has a Change In Inventory of 円0.0 Mil as of Mar. 2026. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for OncoTherapy Science and its competitors.
Is OncoTherapy Science's Change In Inventory too high?
OncoTherapy Science's current Change In Inventory is 円0.0 Mil. Overall, OncoTherapy Science has a GF Score™ of 51/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does OncoTherapy Science's Change In Inventory compare to VRTX and REGN?
OncoTherapy Science's Change In Inventory of 円0.0 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Change In Inventory for a Biotechnology company?
A good Change In Inventory depends on the Biotechnology industry context. However, Change In Inventory should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Change In Inventory mean?
A high Change In Inventory can signal that a stock is expensive relative to its fundamentals. Change in Inventory is the difference between current-period inventory and past-period inventory. View historical data for OncoTherapy Science and its competitors. OncoTherapy Science's current Change In Inventory is 円0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is OncoTherapy Science stock overvalued right now?
Based on GuruFocus' analysis, OncoTherapy Science (TSE:4564) is currently considered Fairly Valued. The stock's GF Value™ is 円18.22, compared to a current price of 円20.00 — trading 9.8% above its estimated fair value. The current Change In Inventory is 円0.0 Mil. OncoTherapy Science's overall GF Score™ is 51/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Change In Inventory calculated?
Change In Inventory is calculated from a company's financial statements. For OncoTherapy Science (TSE:4564), the current Change In Inventory is 円0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is OncoTherapy Science (TSE:4564) Overvalued in 2026?

Based on GuruFocus' analysis, OncoTherapy Science stock appears to be overvalued. The current stock price of 円20.00 is trading 9.8% above its estimated GF Value™ of 円18.22. GuruFocus considers OncoTherapy Science to be Fairly Valued.

Key valuation signals for TSE:4564:

  • Change In Inventory: 円0.0 Mil
  • GF Value™: 円18.22 vs. price of 円20.00 (9.8% above fair value)
  • GF Score™: 51/100 with 1 warning sign

No single metric tells the full story. See the TSE:4564 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

OncoTherapy Science Business Description

Other Exchanges 30O:Germany
Address 11th Floor, Kanagawa Science Park R&D, 3-2-1 Sakado, Kanagawa, Kawasaki, JPN, 213-0012
OncoTherapy Science Inc focuses on cancer-related cells and genes and develops cancer therapy products which include low molecular drugs, antibody drugs, cancer peptide vaccine, and diagnostic medicine in Japan.
51GF Score

Get the complete analysis for TSE:4564

Change In Inventory is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円20.00
Price
円18.22
GF Value